Juvenescence, a biotech start-up seeking to increase human longevity, has closed a $100m funding round. After its Series B financing, the UK-based company ...
from RSSMix.com Mix ID 8318969 https://ift.tt/2KSvDJt
Juvenescence, a biotech start-up seeking to increase human longevity, has closed a $100m funding round. After its Series B financing, the UK-based company ...
No comments:
Post a Comment